- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
已有42家主力机构披露2025-06-30报告期持股数据，持仓量总计2.09亿股，占流通A股35.45%
- 波段诊断：
-
技术面诊股
诊断结果：5.1技术面打败了56%的股票
技术面评分前10的股票
近期的平均成本为5.71元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为5.71元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"5.71","date":1764749610,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。
[{"date":"2025.12.04","stock":"-1.04","trade":"-0.56","ind":"0.40"},{"date":"2025.12.03","stock":"-0.69","trade":"-0.02","ind":"-0.78"},{"date":"2025.12.02","stock":"1.05","trade":"-1.62","ind":"-0.68"},{"date":"2025.12.01","stock":"0.70","trade":"0.00","ind":"1.25"},{"date":"2025.11.28","stock":"0.18","trade":"0.19","ind":"0.85"},{"date":"2025.11.27","stock":"0.53","trade":"-0.26","ind":"-0.25"},{"date":"2025.11.26","stock":"-1.05","trade":"0.65","ind":"1.02"},{"date":"2025.11.25","stock":"3.25","trade":"1.51","ind":"1.53"},{"date":"2025.11.24","stock":"1.47","trade":"1.45","ind":"0.37"},{"date":"2025.11.21","stock":"-5.70","trade":"-3.82","ind":"-3.41"},{"date":"2025.11.20","stock":"-0.52","trade":"-0.92","ind":"-0.76"},{"date":"2025.11.19","stock":"-1.19","trade":"-1.90","ind":"-0.00"},{"date":"2025.11.18","stock":"-0.84","trade":"-0.92","ind":"-0.92"},{"date":"2025.11.17","stock":"-0.67","trade":"-2.18","ind":"-0.11"},{"date":"2025.11.14","stock":"0.67","trade":"0.63","ind":"-1.93"},{"date":"2025.11.13","stock":"0.51","trade":"1.09","ind":"1.78"},{"date":"2025.11.12","stock":"0.68","trade":"0.87","ind":"-0.36"},{"date":"2025.11.11","stock":"-0.17","trade":"0.43","ind":"-1.03"},{"date":"2025.11.10","stock":"1.20","trade":"1.72","ind":"0.18"},{"date":"2025.11.07","stock":"-0.85","trade":"-0.48","ind":"-0.36"},{"date":"2025.11.06","stock":"2.09","trade":"-0.33","ind":"1.73"}]
东宝生物,深证成指,生物制品指数
压力支撑
该股压力位为5.70元，支撑位为5.62元。
[{"text":"\u538b\u529b\u4f4d","value":"5.70","date":1764777600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.62","date":1764777600,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.0资金面打败了44%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：12月04日 17:30
| 机构今日流向(万元) | -102.59 | 机构5日流向(万元) | -4476.14 |
| 机构10日流向(万元) | -7149.51 | 机构20日流向(万元) | -17654.69 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加335.59万股，其中基金净减仓7家，主力净增仓7家，请投资者中长期谨慎为宜。
截止2025-06-30，共42家主力机构（基金36家，一般法人4家，社保基金1家，信托公司1家），持仓量总计20908.57万股，占流通A股35.45%
其中，基金持仓与2024-12-31相比：
增仓：2家 ，增持 0.67万股
减仓：9家 ，减持 34.11万股
新出现在主力名单中：24家 ，持有111.74万股
从主力名单中消失：17家 ，原持有82.36万股
其中，基金持仓与2024-12-31相比：
增仓：2家 ，增持 0.67万股
减仓：9家 ，减持 34.11万股
新出现在主力名单中：24家 ，持有111.74万股
从主力名单中消失：17家 ，原持有82.36万股
消息面诊股
诊断结果：5.5消息面打败了31%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 明胶行业现状与发展趋势深度剖析
2025-11-19 - 东宝生物：公司不涉及稀土领域
2025-11-12 - 东宝生物：公司拥有以天然胶原蛋白肽为基础成分的“胶
2025-11-12 - 东宝生物：公司主要从事明胶、胶原蛋白、空心胶囊及其
2025-11-12 - 行业周报|生物制品指数跌-2.37%, 跑输上证指
2025-11-07 - 股东追踪|广发聚丰混合A新进东宝生物前十大流通股东
2025-10-29 - 东宝生物：第三季度净利润1148.22万元，同比下
2025-10-28 - 东宝生物：公司明胶产品未用于丰胸领域
2025-10-24 - 东宝生物：公司代血浆明胶（药典二部明胶）已经实现销
2025-10-24 - 美股“人造肉第一股”收涨近1.5倍 A股人造肉板块
2025-10-22
消息列表
| 一般消息 | 募资投向 | 2025-09-23 | |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-29 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-05-15 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-24 |
| 利好 | 分红转增 | 10派0.25元(含税) | 2025-04-24 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-24 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-02-17 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-12-26 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：5.3行业面打败了76%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2025.12.04","price":"0.40","value":"-0.56"},{"date":"2025.12.03","price":"-0.78","value":"-0.02"},{"date":"2025.12.02","price":"-0.68","value":"-1.62"},{"date":"2025.12.01","price":"1.25","value":"0.00"},{"date":"2025.11.28","price":"0.85","value":"0.19"},{"date":"2025.11.27","price":"-0.25","value":"-0.26"},{"date":"2025.11.26","price":"1.02","value":"0.65"},{"date":"2025.11.25","price":"1.53","value":"1.51"},{"date":"2025.11.24","price":"0.37","value":"1.45"},{"date":"2025.11.21","price":"-3.41","value":"-3.82"},{"date":"2025.11.20","price":"-0.76","value":"-0.92"},{"date":"2025.11.19","price":"-0.00","value":"-1.90"},{"date":"2025.11.18","price":"-0.92","value":"-0.92"},{"date":"2025.11.17","price":"-0.11","value":"-2.18"},{"date":"2025.11.14","price":"-1.93","value":"0.63"},{"date":"2025.11.13","price":"1.78","value":"1.09"},{"date":"2025.11.12","price":"-0.36","value":"0.87"},{"date":"2025.11.11","price":"-1.03","value":"0.43"},{"date":"2025.11.10","price":"0.18","value":"1.72"},{"date":"2025.11.07","price":"-0.36","value":"-0.48"},{"date":"2025.11.06","price":"1.73","value":"-0.33"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 金迪克 | 54.72% | -7.23% | 5.4分 |
| 2 | 欧林生物 | 22.07% | 9.81% | 7.0分 |
| 3 | 博晖创新 | 16.30% | -1.60% | 4.5分 |
| 4 | 特宝生物 | 11.48% | 6.65% | 6.4分 |
| 5 | 荣昌生物 | 5.28% | -0.66% | 6.6分 |
| 6 | 诺诚健华 | 2.31% | -4.06% | 5.4分 |
| 8 | 万泽股份 | -1.45% | 2.10% | 6.3分 |
| 10 | *ST四环 | -1.96% | -1.96% | 4.7分 |
| 12 | 东宝生物 | -2.73% | 0.18% | 5.1分 |
| 14 | 沃森生物 | -3.15% | -4.42% | 3.9分 |
| 16 | 通化东宝 | -3.31% | 0.00% | 5.8分 |
| 18 | 华兰疫苗 | -3.68% | -11.01% | 5.1分 |
| 20 | 智飞生物 | -4.04% | -2.44% | 4.0分 |
| 22 | 赛升药业 | -4.58% | -4.18% | 3.7分 |
| 24 | 优宁维 | -5.15% | -3.70% | 4.2分 |
| 26 | 华兰生物 | -5.52% | -1.28% | 4.6分 |
| 28 | 长春高新 | -6.26% | -0.27% | 5.0分 |
| 30 | 赛伦生物 | -6.44% | -2.26% | 4.5分 |
| 32 | 博雅生物 | -7.03% | -1.93% | 4.5分 |
| 34 | 我武生物 | -7.23% | -0.55% | 5.1分 |
| 36 | 天坛生物 | -7.61% | -2.52% | 4.8分 |
| 38 | 康泰生物 | -8.01% | -3.96% | 4.0分 |
| 40 | 昊帆生物 | -8.29% | -2.66% | 3.9分 |
| 42 | ST未名 | -9.11% | -6.82% | 3.8分 |
| 44 | 安科生物 | -9.73% | -2.62% | 4.2分 |
| 46 | 百奥泰 | -10.07% | -6.01% | 4.4分 |
| 48 | 义翘神州 | -10.11% | -0.92% | 4.8分 |
| 50 | 康希诺 | -11.74% | -4.20% | 4.0分 |
| 52 | - | -13.66% | -5.31% | 分 |
| 54 | - | -14.96% | -5.40% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 26/72 ， 49/72。
[{"date":"2025-09-30","value":"2.80","vol":"-9.78"},{"date":"2025-06-30","value":"2.15","vol":"-0.61"},{"date":"2025-03-31","value":"1.10","vol":"0.46"},{"date":"2024-12-31","value":"5.06","vol":"-0.68"},{"date":"2024-09-30","value":"3.92","vol":"1.34"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.80 | 2.15 | 1.10 | 5.06 | 3.92 |
| 行业(%) | -9.78 | -0.61 | 0.46 | -0.68 | 1.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"24.53","vol":"67.61"},{"date":"2025-06-30","value":"25.44","vol":"68.28"},{"date":"2025-03-31","value":"25.06","vol":"68.43"},{"date":"2024-12-31","value":"22.72","vol":"69.85"},{"date":"2024-09-30","value":"22.62","vol":"70.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
24.53 | 25.44 | 25.06 | 22.72 | 22.62 |
| 行业(%) | 67.61 | 68.28 | 68.43 | 69.85 | 70.47 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 45/72 ， 36/72。
[{"date":"2025-09-30","value":"-15.84","vol":"45.25"},{"date":"2025-06-30","value":"-16.93","vol":"6902.04"},{"date":"2025-03-31","value":"-22.23","vol":"6125.27"},{"date":"2024-12-31","value":"-9.19","vol":"47.35"},{"date":"2024-09-30","value":"-13.82","vol":"175.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-15.84 | -16.93 | -22.23 | -9.19 | -13.82 |
| 行业(%) | 45.25 | 6902.04 | 6125.27 | 47.35 | 175.00 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-26.89","vol":"44.80"},{"date":"2025-06-30","value":"-28.00","vol":"5.44"},{"date":"2025-03-31","value":"-26.64","vol":"-8.46"},{"date":"2024-12-31","value":"-28.28","vol":"-9.81"},{"date":"2024-09-30","value":"-30.43","vol":"-52.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-26.89 | -28.00 | -26.64 | -28.28 | -30.43 |
| 行业(%) | 44.80 | 5.44 | -8.46 | -9.81 | -52.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 23/72 ， 13/72。
[{"date":"2025-09-30","value":"0.21","vol":"0.22"},{"date":"2025-06-30","value":"0.14","vol":"0.14"},{"date":"2025-03-31","value":"0.07","vol":"0.06"},{"date":"2024-12-31","value":"0.33","vol":"0.29"},{"date":"2024-09-30","value":"0.23","vol":"0.22"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.21 | 0.14 | 0.07 | 0.33 | 0.23 |
| 行业(次) | 0.22 | 0.14 | 0.06 | 0.29 | 0.22 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.04","vol":"0.92"},{"date":"2025-06-30","value":"0.74","vol":"0.56"},{"date":"2025-03-31","value":"0.39","vol":"0.26"},{"date":"2024-12-31","value":"2.15","vol":"1.17"},{"date":"2024-09-30","value":"1.48","vol":"0.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.04 | 0.74 | 0.39 | 2.15 | 1.48 |
| 行业(次) | 0.92 | 0.56 | 0.26 | 1.17 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"6.79","vol":"1.84"},{"date":"2025-06-30","value":"48.52","vol":"-1377.61"},{"date":"2025-03-31","value":"-19.96","vol":"-46.99"},{"date":"2024-12-31","value":"15.83","vol":"-11.33"},{"date":"2024-09-30","value":"-16.35","vol":"-30.88"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 6.79 | 48.52 | -19.96 | 15.83 | -16.35 |
| 行业 | 1.84 | -1377.61 | -46.99 | -11.33 | -30.88 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.60","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.88","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.60 | - | 0.88 | - |
| 行业 | 0.00 | 1.59 | 0.00 | 2.01 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 36/72 ， 34/72。
[{"date":"2025-09-30","value":"4.90","vol":"6.00"},{"date":"2025-06-30","value":"4.37","vol":"6.64"},{"date":"2025-03-31","value":"4.49","vol":"7.75"},{"date":"2024-12-31","value":"3.81","vol":"6.72"},{"date":"2024-09-30","value":"3.00","vol":"7.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.90 | 4.37 | 4.49 | 3.81 | 3.00 |
| 行业 | 6.00 | 6.64 | 7.75 | 6.72 | 7.02 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"3.07","vol":"4.84"},{"date":"2025-06-30","value":"2.87","vol":"5.30"},{"date":"2025-03-31","value":"3.06","vol":"6.35"},{"date":"2024-12-31","value":"2.68","vol":"5.40"},{"date":"2024-09-30","value":"2.10","vol":"5.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.07 | 2.87 | 3.06 | 2.68 | 2.10 |
| 行业 | 4.84 | 5.30 | 6.35 | 5.40 | 5.66 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 14/72 ， 19/72。
[{"date":"2025-09-30","value":"32.50","vol":"28.18"},{"date":"2025-06-30","value":"33.79","vol":"26.73"},{"date":"2025-03-31","value":"33.71","vol":"26.03"},{"date":"2024-12-31","value":"33.73","vol":"25.81"},{"date":"2024-09-30","value":"36.68","vol":"24.44"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
32.50 | 33.79 | 33.71 | 33.73 | 36.68 |
| 行业(%) | 28.18 | 26.73 | 26.03 | 25.81 | 24.44 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.48","vol":"0.58"},{"date":"2025-06-30","value":"0.51","vol":"1.11"},{"date":"2025-03-31","value":"0.51","vol":"0.78"},{"date":"2024-12-31","value":"0.51","vol":"0.87"},{"date":"2024-09-30","value":"0.58","vol":"0.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.48 | 0.51 | 0.51 | 0.51 | 0.58 |
| 行业(%) | 0.58 | 1.11 | 0.78 | 0.87 | 0.40 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"0.36","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"1.09","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.20","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.86","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]